Presentation TCT 2018 Cases to Avoid and Complication Management Presenter: Ali F. Aboufares September 23, 2018 REGISTER for free or LOG IN to view this content Endovascular Presentation TCT 2018 Up Next Presentation TCT 2018 EWOLUTION: Two-Year Efficacy of Left Atrial Appendage Closure in High-Risk Patients - Single Antiplatelet/No Therapy Subgroup Analysis Presenter: Martin W. Bergmann September 23, 2018 More slides + Presentation TCT 2018 TAVI/LAAO: A Randomized Trial of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation Presenter: Fabian Nietlispach September 23, 2018 Presentation TCT 2018 OBSERVANT: Five-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in a Low/Intermediate-Risk Real-world Population Presenter: Marco Barbanti September 23, 2018 We Recommend
Presentation TCT 2018 EWOLUTION: Two-Year Efficacy of Left Atrial Appendage Closure in High-Risk Patients - Single Antiplatelet/No Therapy Subgroup Analysis Presenter: Martin W. Bergmann September 23, 2018
Presentation TCT 2018 TAVI/LAAO: A Randomized Trial of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation Presenter: Fabian Nietlispach September 23, 2018
Presentation TCT 2018 OBSERVANT: Five-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in a Low/Intermediate-Risk Real-world Population Presenter: Marco Barbanti September 23, 2018